Search Results - "Yeargin, Jo"

Early human prostate adenocarcinomas harbor androgen-independent cancer cells by Fiñones, Rita R, Yeargin, Jo, Lee, Melissa, Kaur, Aman Preet, Cheng, Clari, Sun, Paulina, Wu, Christopher, Nguyen, Catherine, Wang-Rodriguez, Jessica, Meyer, April N, Baird, Stephen M, Donoghue, Daniel J, Haas, Martin

“…Although blockade of androgen receptor (AR) signaling represents the main treatment for advanced prostate cancer (PrCa), many patients progress to a lethal…”
Get full text

Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene by JIAN CHENG, JILING-KUAN YEE, YEARGIN, J, FRIEDMANN, T, HAAS, M

“…Independent mutations in both alleles of the p53 tumor suppressor gene are a frequent finding in human T-cell acute lymphoblastic leukemia (T-ALL) cell lines…”
Get full text

P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines by JO YEARGIN, YU, A. L, GJERSET, R, BOGART, M, HAAS, M

“…Samples donated by patients with T cell acute lymphoblastic leukemia (T-ALL) were screened for mutations of the p53 tumor suppressor gene. Peripheral blood…”
Get full text

Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest by Yeargin, Jo, Haas, Martin

“…Background: The tumor suppressor protein p53 regulates progression through the checkpoint between the G1 and S phases of the cell cycle in response to…”
Get full text

Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness by Hsiao, M, Low, J, Dorn, E, Ku, D, Pattengale, P, Yeargin, J, Haas, M

“…Leukemia cell infiltration and the induction of lethal hematopoietic disease in immune-deficient SCID mice transplanted with human T cell acute lymphoblastic T…”
Get full text

Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase by HSIAO, M. H, YU, A. L, YEARGIN, J, KU, D, HAAS, M

“…We have previously reported that greater than 60% of human leukemic T-cell lines possess mutations in the p53 tumor suppressor gene. To determine whether…”
Get full text

Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype by Gjerset, RA, Yeargin, J, Volkman, SK, Vila, V, Arya, J, Haas, M

“…We have studied the phenotypic characteristics and growth properties of murine T lymphoma cell lines derived from primary x-ray-induced thymic lymphomas at the…”
Get full text

Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53 by Hsiao, M, Wu, C Y, Low, J, Pattengale, P, Yeargin, J, Haas, M

“…Approximately 60% of mice treated with split-dose radiation develop leukemias that disseminate widely through the body, whereas 40% of the treated mice incur…”
Get more information